OHR Pharmaceutical Inc (NASDAQ:OHRP) soared today after Vista Partners updated its coverage for the pharmaceuticals company. Vista Partners has increased its twelve-month target price for OHR Pharmaceutical stock from $14 to $31. OHR Pharmaceutical Inc (NASDAQ:OHRP) stock performance was 35.43% in last session and finished the day at $9.90. Traded volume was 5.84million shares in the last session and the average volume of the stock remained 401.32K shares. The beta of the stock remained -6.26. OHR Pharmaceutical Inc (NASDAQ:OHRP) insider ownership is 2.60%.
In corporate news, Glu Mobile Inc. (NASDAQ:GLUU) was up 7.41% after it said it will support Google’s (GOOG) Android TV platform, and that Glu’s Deer Hunter 201 and Eternity Warriors 2 games are available immediately on the platform. Glum Mobile Inc. (NASDAQ:GLUU), a developer of free-to-play games for mobile devices, said Android TV will allow the company to extend gameplay on a cross-platform basis into the living room. The company said it would also integrate Google Play Game Services into multiple Glu titles. Glu Mobile Inc. (NASDAQ:GLUU) rose 9.88 percent to $4.45 Thursday on volume of 13.46million shares. The intra-day range of the stock was $4.22 to $4.52. Glu Mobile Inc. (NASDAQ:GLUU) has a market capitalization of $399.98million.
Joint-venture partner Royale Energy Inc. (NASDAQ:ROYL) announced its survey in March, which covered more than 100 sq miles (OGJ Online, Mar. 6, 2014). The JV’s 100,000 acres are situated within the peak oil generating and volatiles windows of the Shublik and Lower Kingak shales. Royale Energy, Inc. (NASDAQ:ROYL)’s stock on June 26, 2014 reported a increase of 10.63% to the closing price of $3.33. Its fifty two weeks range is $2.42 -$4.12. The total market capitalization recorded $49.76million. The overall volume in the last trading session was 2.15million shares. In its share capital, ROYL has 14.95million outstanding shares.
Organovo Holdings Inc (NYSEMKT:ONVO) is a very interesting company in that it provides 3-D bioprinting technology that allows customers to print human tissue for use in drug testing. It’s a fascinating concept, and one with potentially major implications, as it could make the drug approval process potentially much better because it would give companies a better idea whether to pursue an idea, or move on to the next one without wasting additional funds. On Thursday, shares of Organovo Holdings Inc (NYSEMKT:ONVO) advanced 11.72% to close the day at $8.20. Company return on investment (ROI) is -42.30% and its monthly performance is recorded as 17.65%. Organovo Holdings Inc (NYSEMKT:ONVO) quarterly revenue growth is 13.26%.
Methode Electronics Inc. (NYSE:MEI) issued an update on its FY15 earnings guidance on Thursday morning. The company provided EPS guidance of $1.85-2.00 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.98, Stock Ratings News reports. The company issued revenue guidance of $835-860 million, compared to the consensus revenue estimate of $812.10 million. Methode Electronics Inc. (NYSE:MEI) stock performance was 14.11% in last session and finished the day at $37.68. Traded volume was 2.24million shares in the last session and the average volume of the stock remained 339.74K shares. The beta of the stock remained 1.18. Methode Electronics Inc. (NYSE:MEI) insider ownership is 0.90%.